Marta
Llanos Muñoz

Profesora Asociada Asistencial

Foto de Marta

Foto de Instituto de Salud Carlos III

Instituto de Salud Carlos III

Madrid, España

Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2018

First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183

2017

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group
Cancer, Vol. 123, Núm. 19, pp. 3709-3716

2012

First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103